

PLx Pharma develops and commercializes non-steroidal anti-inflammatory drugs for prescription and over-the-counter markets. Among its major competitors, PLx Pharma is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $2.53M